Cargando…
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analy...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317365/ https://www.ncbi.nlm.nih.gov/pubmed/34320944 http://dx.doi.org/10.1186/s12885-021-08576-z |
_version_ | 1783730056272543744 |
---|---|
author | Cavalloni, Giuliana Peraldo-Neia, Caterina Massa, Annamaria Bergamini, Carlo Trentini, Alessandro De Rosa, Giovanni Daniele, Lorenzo Ciccosanti, Fabiola Cervellati, Carlo Leone, Francesco Aglietta, Massimo |
author_facet | Cavalloni, Giuliana Peraldo-Neia, Caterina Massa, Annamaria Bergamini, Carlo Trentini, Alessandro De Rosa, Giovanni Daniele, Lorenzo Ciccosanti, Fabiola Cervellati, Carlo Leone, Francesco Aglietta, Massimo |
author_sort | Cavalloni, Giuliana |
collection | PubMed |
description | BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analyzed the proteomic profile of five intrahepatic cholangiocarcinoma (ICC) derived from Italian patients undergone surgery and one normal bile duct cell line. METHODS: Proteome profile was investigated by using 2D electrophoresis followed by Mass Spectrometry (MS). To validate proteomic data, the expression of four overexpressed proteins (CAT, SOD, PRDX6, DBI/ACBP) was evaluated by immunohistochemistry in an independent cohort of formalin fixed, paraffin-embedded (FFPE) ICC tissues. We also compared proteomic data with those obtained by transcriptomic profile evaluated by microarray analysis of the same tissues. RESULTS: We identified 19 differentially expressed protein spots, which were further characterized by MS; 13 of them were up- and 6 were down-regulated in ICC. These proteins are mainly involved in redox processes (CAT, SODM, PRDX2, PRDX6), in metabolism (ACBP, ACY1, UCRI, FTCD, HCMS2), and cell structure and organization (TUB2, ACTB). CAT is overexpressed in 86% of patients, PRDX6 in 73%, SODM in 100%, and DBI/ACBP in 81% compared to normal adjacent tissues. A concordance of 50% between proteomic and transcriptomic data was observed. CONCLUSIONS: This study pointed out that the impairment of the metabolic and antioxidant systems, with a subsequent accumulation of free radicals, might be a key step in CCA development and progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08576-z. |
format | Online Article Text |
id | pubmed-8317365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83173652021-07-28 Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients Cavalloni, Giuliana Peraldo-Neia, Caterina Massa, Annamaria Bergamini, Carlo Trentini, Alessandro De Rosa, Giovanni Daniele, Lorenzo Ciccosanti, Fabiola Cervellati, Carlo Leone, Francesco Aglietta, Massimo BMC Cancer Research BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analyzed the proteomic profile of five intrahepatic cholangiocarcinoma (ICC) derived from Italian patients undergone surgery and one normal bile duct cell line. METHODS: Proteome profile was investigated by using 2D electrophoresis followed by Mass Spectrometry (MS). To validate proteomic data, the expression of four overexpressed proteins (CAT, SOD, PRDX6, DBI/ACBP) was evaluated by immunohistochemistry in an independent cohort of formalin fixed, paraffin-embedded (FFPE) ICC tissues. We also compared proteomic data with those obtained by transcriptomic profile evaluated by microarray analysis of the same tissues. RESULTS: We identified 19 differentially expressed protein spots, which were further characterized by MS; 13 of them were up- and 6 were down-regulated in ICC. These proteins are mainly involved in redox processes (CAT, SODM, PRDX2, PRDX6), in metabolism (ACBP, ACY1, UCRI, FTCD, HCMS2), and cell structure and organization (TUB2, ACTB). CAT is overexpressed in 86% of patients, PRDX6 in 73%, SODM in 100%, and DBI/ACBP in 81% compared to normal adjacent tissues. A concordance of 50% between proteomic and transcriptomic data was observed. CONCLUSIONS: This study pointed out that the impairment of the metabolic and antioxidant systems, with a subsequent accumulation of free radicals, might be a key step in CCA development and progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08576-z. BioMed Central 2021-07-28 /pmc/articles/PMC8317365/ /pubmed/34320944 http://dx.doi.org/10.1186/s12885-021-08576-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cavalloni, Giuliana Peraldo-Neia, Caterina Massa, Annamaria Bergamini, Carlo Trentini, Alessandro De Rosa, Giovanni Daniele, Lorenzo Ciccosanti, Fabiola Cervellati, Carlo Leone, Francesco Aglietta, Massimo Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients |
title | Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients |
title_full | Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients |
title_fullStr | Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients |
title_full_unstemmed | Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients |
title_short | Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients |
title_sort | proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in italian intrahepatic cholangiocarcinoma patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317365/ https://www.ncbi.nlm.nih.gov/pubmed/34320944 http://dx.doi.org/10.1186/s12885-021-08576-z |
work_keys_str_mv | AT cavallonigiuliana proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT peraldoneiacaterina proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT massaannamaria proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT bergaminicarlo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT trentinialessandro proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT derosagiovanni proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT danielelorenzo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT ciccosantifabiola proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT cervellaticarlo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT leonefrancesco proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients AT agliettamassimo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients |